OUR WHY
STAT Chemo Trainers is a training and consulting organization focused on two things:
Training nurses how to safely & competently administer chemotherapy & biotherapy to patients.
-AND-
Helping healthcare organizations meet the needs of caring for their growing hematology & oncology patient population.
We seek to train more chemotherapy/biotherapy nurses and support healthcare organizations.
OUR APPROACH, YOUR SUCCESS
We understand how difficult it can be to offer regular chemo/bio courses to train your nurses.
We offer monthly APHON Peds Chemo/Bio Courses.
Need more personalized support in training your nurses?
Let us know what days you need training and we can accommodate your staffing schedule to meet your unit's needs.
Founder, Trainer
Stephanie Darden, RN, BSN, CPHON
"Helping patients get the life-saving treatment they need is very rewarding and fulfilling as a nurse. I am excited to train more nurses and support healthcare organizations in caring for this special patient population that I hold close to my heart."
Clinical Qualifications
5+ years of administering chemotherapy and biotherapy
Certified Pediatric Hematology Oncology Nurse (CPHON)
APHON Pediatric Chemotherapy and Biotherapy Instructor
In-depth clinical knowledge and experience administering chemotherapy/biotherapy to pediatric and adults
APHON Pediatric Chemo Biotherapy Provider
ONS Adult Chemo Biotherapy Provider
Stephanie Darden is the proud Founder of STAT Chemo Trainers. She is a Hematology/Oncology Registered Nurse and a Certified Pediatric Hematology Oncology Nurse.
She started STAT Chemo Trainers because she saw an increasing need for chemotherapy-trained nurses to care for the growing oncology patient population. Healthcare organizations today are tasked to meet the challenges in caring for the increasing growing oncology patient population.
We help healthcare organizations train their nurses with highly specialized chemotherapy & biotherapy training. We are passionate about this work because we want to support nurses and be able to reach more patients undergoing life-saving chemotherapy treatments.
